Robert Nelsen is Director of Karuna Therapeutics, Inc.. Currently has a direct ownership of 5,269 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Apr 13, 2021, when has been sold 1,756 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.27K
0% 3M change
0% 12M change
Total Value Held $0

ROBERT NELSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 13 2021
BUY
Other acquisition or disposition
-
1,756 Added 25.0%
5,269 Common Stock
Jan 08 2021
BUY
Other acquisition or disposition
-
1,756 Added 33.33%
3,513 Common Stock
Nov 12 2020
BUY
Other acquisition or disposition
-
1,757 Added 50.0%
1,757 Common Stock

Also insider at

BEAM
Beam Therapeutics Inc. Healthcare
SANA
Sana Biotechnology, Inc. Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
DNLI
Denali Therapeutics Inc. Healthcare
LYEL
Lyell Immunopharma, Inc. Healthcare
PRME
Prime Medicine, Inc.
RN

Robert Nelsen

Director
Chicago, IL

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if
Any

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX